Pozniak A - Search Results

1

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.

Churchill D, Waters L, Ahmed N, Angus B, Boffito M, Bower M, Dunn D, Edwards S, Emerson C, Fidler S, Fisher M, Horne R, Khoo S, Leen C, Mackie N, Marshall N, Monteiro F, Nelson M, Orkin C, Palfreeman A, Pett S, Phillips A, Post F, Pozniak A, Reeves I, Sabin C, Trevelion R, Walsh J, Wilkins E, Williams I, Winston A. Churchill D, et al. Among authors: pozniak a. HIV Med. 2016 Aug;17 Suppl 4:s2-s104. doi: 10.1111/hiv.12426. HIV Med. 2016. PMID: 27568911 Free article. No abstract available.

2

Markers of immune cell activation and disease progression. Cell activation in HIV disease.

Peakman M, Mahalingam M, Pozniak A, McManus TJ, Phillips AN, Vergani D. Peakman M, et al. Among authors: pozniak a. Adv Exp Med Biol. 1995;374:17-26. doi: 10.1007/978-1-4615-1995-9_2. Adv Exp Med Biol. 1995. PMID: 7572390

3

Summary of track B: clinical science.

De Cock KM, Churchill D, Grant A, Del Amo J, Rouleau D, Zala C, Harris M, Pozniak A, Williams I. De Cock KM, et al. Among authors: pozniak a. AIDS. 1996 Dec;10 Suppl 3:S107-13. AIDS. 1996. PMID: 8970717 Review.

4

Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.

Pozniak A, Nelson MR. Pozniak A, et al. Genitourin Med. 1996 Aug;72(4):269-71. doi: 10.1136/sti.72.4.269. Genitourin Med. 1996. PMID: 8976832 Free PMC article. Review. No abstract available.

5

Localised oral histoplasmosis lesions associated with HIV infection.

Warnakulasuriya KA, Harrison JD, Johnson NW, Edwards S, Taylor C, Pozniak AL. Warnakulasuriya KA, et al. Among authors: pozniak al. J Oral Pathol Med. 1997 Jul;26(6):294-6. doi: 10.1111/j.1600-0714.1997.tb01240.x. J Oral Pathol Med. 1997. PMID: 9234191

6

ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey.

Gill JK, Greene L, Miller R, Pozniak A, Cartledge J, Fisher M, Nelson MR, Soni N. Gill JK, et al. Among authors: pozniak a. Anaesthesia. 1999 Aug;54(8):727-32. doi: 10.1046/j.1365-2044.1999.00903.x. Anaesthesia. 1999. PMID: 10460523 Free article.

7

Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. National Prospective Monitoring System Steering Group.

Beck EJ, Mandalia S, Williams I, Power A, Newson R, Molesworth A, Barlow D, Easterbrook P, Fisher M, Innes J, Kinghorn G, Mandel B, Pozniak A, Tang A, Tomlinson D. Beck EJ, et al. Among authors: pozniak a. AIDS. 1999 Oct 22;13(15):2157-64. doi: 10.1097/00002030-199910220-00020. AIDS. 1999. PMID: 10546870

8

Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine.

Sabin CA, Fisher M, Churchill D, Pozniak A, Hay P, Easterbrook P, Williams I. Sabin CA, et al. Among authors: pozniak a. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):462-5. doi: 10.1097/00126334-200104150-00009. J Acquir Immune Defic Syndr. 2001. PMID: 11391166 Clinical Trial.

9

Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors.

Torti C, Pozniak A, Nelson M, Hertogs K, Gazzard BG. Torti C, et al. Among authors: pozniak a. J Antimicrob Chemother. 2001 Jul;48(1):113-6. doi: 10.1093/jac/48.1.113. J Antimicrob Chemother. 2001. PMID: 11418520

10

Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?

Pozniak AL. Pozniak AL. HIV Med. 2000;1 Suppl 1:7-10. doi: 10.1046/j.1468-1293.2000.00006.x. HIV Med. 2000. PMID: 11737361 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

552 results

Search Page